SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES
13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)
(Amendment No. 1)*
Spectrum Pharmaceuticals, Inc.
------------------------------------
(Name of Issuer)
Common Stock, par value $0.001 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
640656104
--------------
(CUSIP Number)
April 22, 2003
-------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13G
CUSIP NO. 640656104 Page 2 of 7
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
Cranshire Capital, L.P.
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES N/A
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY N/A
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING N/A
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH N/A
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
N/A
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 5%
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
PN
-----------------------------------------------------------------------------
SCHEDULE 13G
CUSIP NO. 640656104 Page 3 of 7
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
Downsview Capital, Inc.
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES N/A
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY N/A
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING N/A
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH N/A
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
N/A
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 5%
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
CO
-----------------------------------------------------------------------------
SCHEDULE 13G
CUSIP NO. 640656104 Page 4 of 7
-----------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (Entities Only)
Mitchell P. Kopin
-----------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
-----------------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
-----------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES N/A
--------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY N/A
--------------------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING N/A
--------------------------------------------------------------
PERSON 8 SHARED DISPOSITIVE POWER
WITH N/A
-----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
N/A
-----------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
-----------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 5%
-----------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
IN
-----------------------------------------------------------------------------
SCHEDULE 13G
CUSIP NO. 640656104 Page 5 of 7
Item 1(a). Name of Issuer:
Spectrum Pharmaceuticals, Inc., a Delaware corporation (the "Issuer")
Item 1(b). Address of Issuer 's Principal Executive Offices:
157 Technology Drive
Irvine, California 92618
Items 2(a), (b) and (c). Name of Persons Filing, Address of Principal Business
Office and Citizenship:
This Amendment No. 1 to Schedule 13G is being filed on behalf of (i)
Cranshire Capital, L.P., an Illinois limited partnership
("Cranshire"), (ii) Downsview Capital, Inc., a Illinois corporation
("Downsview") and (iii) Mitchell P. Kopin, an individual who is a
citizen of the U.S.A. ("Kopin," together with Cranshire and
Downsview, the "Reporting Persons").
The Reporting Persons have entered into a Joint Filing Agreement, a
copy of which was previously filed as Exhibit 1 to the initial
Schedule 13G, filed on January 27, 2003, pursuant to which the
Reporting Persons agreed to file the initial Schedule 13G and any
amendments thereto jointly in accordance with the provisions of Rule
13d-1(k) of the Securities Exchange Act of 1934, as amended.
The principal business office of each of the Reporting Persons is 666
Dundee Road, Suite 1901, Northbrook, Illinois, 60062.
Item 2(d). Title of Class of Securities:
Common Stock, par value $0.001 per share, of the Issuer (the "Common
Stock")
Item 2(e). CUSIP Number:
640656104
Item 3. Not applicable.
Item 4. Ownership.
(a) Amount beneficially owned:
N/A
(b) Percent of class:
Less than 5%
SCHEDULE 13G
CUSIP NO. 640656104 Page 6 of 7
(c) Number of shares to which such person has:
(i) Sole power to vote or direct the vote: N/A
(ii) Shared power to vote or direct the vote: N/A
(iii) Sole power to dispose or to direct the disposition of: N/A
(iv) Shared power to dispose of or direct the disposition of:
N/A
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the
date hereof the reporting persons have ceased to be the beneficial
owner of more than five percent of the class of securities, check the
following [X].
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
N/A
Item 7. Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported By the Parent Holding Company.
N/A
Item 8. Identification and Classification of Members of the Group.
N/A
Item 9. Notice of Dissolution of a Group.
N/A
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were not
acquired and are not held in connection with or as a participant in
any transaction having that purpose or effect.
SCHEDULE 13G
CUSIP NO. 640656104 Page 7 of 7
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: May 5, 2003
CRANSHIRE CAPITAL, L.P.
By: Downsview Capital, Inc.,
its general partner
By:/s/ Mitchell P. Kopin
------------------------------
Mitchell P. Kopin, President
DOWNSVIEW CAPITAL, INC.
By:/s/ Mitchell P. Kopin
-------------------------------
Mitchell P. Kopin, President
/s/ Mitchell P. Kopin
--------------------------------
Mitchell P. Kopin